+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Conjugated Estrogens"

U.S. Sex Reassignment Hormone Therapy Market Size, Share & Trends Analysis Report By Gender Transition (Male-To-Female, Female-To-Male), By Type (Puberty Blockers, Estrogen), By Distribution Channel, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

U.S. Sex Reassignment Hormone Therapy Market Size, Share & Trends Analysis Report By Gender Transition (Male-To-Female, Female-To-Male), By Type (Puberty Blockers, Estrogen), By Distribution Channel, And Segment Forecasts, 2023 - 2030

  • Report
  • August 2023
  • 150 Pages
  • United States
From
Osteoporosis: Global Drug Forecast and Market Analysis to 2027 - Product Thumbnail Image

Osteoporosis: Global Drug Forecast and Market Analysis to 2027

  • Report
  • March 2019
  • 195 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Conjugated Estrogens are a type of Endocrine and Metabolic Disorders Drugs used to treat menopausal symptoms, such as hot flashes, vaginal dryness, and night sweats. They are also used to treat osteoporosis in postmenopausal women, as well as to reduce the risk of developing endometrial hyperplasia. Conjugated Estrogens are available in both oral and topical forms, and are often prescribed in combination with other medications. Conjugated Estrogens are generally considered safe and effective, but may cause side effects such as nausea, headache, and breast tenderness. Long-term use of Conjugated Estrogens may increase the risk of certain types of cancer, such as breast and ovarian cancer. Some companies in the Conjugated Estrogens market include Pfizer, Merck, Novartis, and Mylan. Show Less Read more